CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA 1/2 carriers and non-carriers

British Journal of Cancer

Volumn 85, Issue 1, 2001, Pages 36-40

  Kadouri, L ^a,b   Easton, D F ^c   Edwards, S ^b   Hubert, A ^a   Kote Jarai, Z ^b   Glaser, B ^a   Durocher, F ^c   Abeliovich, D ^a   Peretz, T ^a   Eeles, R A ^b,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Androgen receptor; BRCA 1 2; Breast cancer risk; Polymorphisms

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ETHNIC GROUP; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; NUCLEOTIDE REPEAT; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; JEWS; MIDDLE AGED; NEOPLASM PROTEINS; PENETRANCE; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS;

EID: 17844364872     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1777     Document Type: Article

References (24)

1. Adrenal androgen and human breast cancer: A new appraisal
2. Relation between urinary androgen and corticosteroids excretion and subsequent breast cancer
3. Elevated serum estradiol and testosterone concentration are associated with a high risk for breast cancer
4. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancel
5. Breast and ovarian cancer incidence in BRCA1 mutation carriers
6. Genetic variation in five trimeric and tandem repeat loci in four human population groups
7. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival
8. Genetic heterogeneity and penetrance analysis of BRCA1 and BRCA2 genes in breast cancer families
9. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulation of men with prostate cancer
10. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
11. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors
12. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenic relevance for the (CAG)n expanded neuropaties
13. The clinical significance of androgen receptor in breast cancer and its relation to histological and cell biological parameters
14. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
15. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
16. Modification of BRCA1-associated breast cancer risk by polymorphic androgen-receptor CAG repeat
17. Androgen and breast cancer in premenopausal women
18. Serum and urinary androgens and the risk of BC in postmenopausal women
19. Trinucleotide repeat polymorphism in the human androgen receptor gene (AR)
20. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene
21. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years
22. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
23. Population-based study of risk of breast cancer in carriers of BRCA2 mutations
24. CAG repeat of the androgen receptor gene and its association with survival